AGC
Aspen Grove Capital’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Buy |
4,403
+403
| +10% | +$314K | 0.58% | 29 |
|
|
2025
Q1 | $3.3M | Buy |
4,000
+21
| +0.5% | +$17.3K | 0.64% | 26 |
|
|
2024
Q4 | $3.07M | Buy |
3,979
+4
| +0.1% | +$3.09K | 0.65% | 29 |
|
|
2024
Q3 | $3.52M | Sell |
3,975
-66
| -2% | -$58.5K | 0.78% | 22 |
|
|
2024
Q2 | $3.66M | Buy |
4,041
+64
| +2% | +$57.9K | 0.86% | 21 |
|
|
2024
Q1 | $3.09M | Buy |
3,977
+76
| +2% | +$59.1K | 0.88% | 22 |
|
|
2023
Q4 | $2.26M | Buy |
3,901
+69
| +2% | +$40.1K | 0.69% | 31 |
|
|
2023
Q3 | $2.06M | Buy |
3,832
+2,267
| +145% | +$1.22M | 0.76% | 29 |
|
|
2023
Q2 | $734K | Buy |
1,565
+520
| +50% | +$244K | 0.24% | 83 |
|
|
2023
Q1 | $359K | Buy |
1,045
+152
| +17% | +$52.2K | 0.16% | 104 |
|
|
2022
Q4 | $327K | Buy |
+893
| New | +$327K | 0.15% | 105 |
|